Potentially modifiable factors associated with longitudinal health-related quality of life in the National Unified Renal Translational Research Enterprise CKD (NURTuRE-CKD) cohort.

IF 3.2 3区 医学 Q1 UROLOGY & NEPHROLOGY
Thomas Phillips, Scott Harris, Olalekan Lee Aiyegbusi, Melissa Benavente, Paul Cockwell, Philip A Kalra, Paul J Roderick, David C Wheeler, Maarten W Taal, Simon D S Fraser
{"title":"Potentially modifiable factors associated with longitudinal health-related quality of life in the National Unified Renal Translational Research Enterprise CKD (NURTuRE-CKD) cohort.","authors":"Thomas Phillips, Scott Harris, Olalekan Lee Aiyegbusi, Melissa Benavente, Paul Cockwell, Philip A Kalra, Paul J Roderick, David C Wheeler, Maarten W Taal, Simon D S Fraser","doi":"10.1159/000551177","DOIUrl":null,"url":null,"abstract":"<p><p>Introduction People with non-dialysis-dependent chronic kidney disease (NDD-CKD) experience worse health-related quality of life (HRQoL) than those without. This study hypothesised that potentially modifiable factors affecting longitudinal HRQoL in a NDD-CKD cohort could be identified in order to identify potential therapeutic targets for improving HRQoL outcomes. Methods The NURTuRE-CKD cohort study recruited 2996 participants with NDD-CKD from UK nephrology centres from 2017. Sociodemographic, medical history, medication, anthropometric, biomarker and patient-reported outcome measure (PROM) data were collected at baseline and first follow-up. HRQoL was measured at second follow-up. The primary outcome was HRQoL measured by EQ-5D-5L, mapped to EQ-5D-3L index value and visual analogue score (VAS). Multivariable mixed effects linear regression models were adjusted and fit to examine the effect of potentially modifiable factors at baseline on longitudinal EQ-5D-3L index value. Similar models were also fit to assess the effects of change in these factors across follow-up on index value and VAS. Results 2062 participants (68.8%) attended first and 1019 (34.0%) second follow-up. EQ-5D-5L responses worsened over time for index value, VAS and in each dimension. Baseline factors independently associated with worse longitudinal HRQoL were obesity, smoking, sarcopenia, pain, breathlessness, weakness, anxiety, depression and raised parathyroid hormone (PTH), whereas renin-angiotensin-system inhibitor use at baseline was associated with improved HRQoL. The status of factors across follow-up such as persistent obesity, new sarcopenia, increasing phosphate, new and persistent anxiety and depression, and worsening pain were associated with worse HRQoL, whereas improved acidosis, improved pain and weakness were associated with improved HRQoL. Conclusion Several potentially modifiable factors independently associated with HRQoL, and NDD-CKD interventions should consider these as therapeutic targets, as well as part of holistic CKD care.</p>","PeriodicalId":7570,"journal":{"name":"American Journal of Nephrology","volume":" ","pages":"1-29"},"PeriodicalIF":3.2000,"publicationDate":"2026-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000551177","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction People with non-dialysis-dependent chronic kidney disease (NDD-CKD) experience worse health-related quality of life (HRQoL) than those without. This study hypothesised that potentially modifiable factors affecting longitudinal HRQoL in a NDD-CKD cohort could be identified in order to identify potential therapeutic targets for improving HRQoL outcomes. Methods The NURTuRE-CKD cohort study recruited 2996 participants with NDD-CKD from UK nephrology centres from 2017. Sociodemographic, medical history, medication, anthropometric, biomarker and patient-reported outcome measure (PROM) data were collected at baseline and first follow-up. HRQoL was measured at second follow-up. The primary outcome was HRQoL measured by EQ-5D-5L, mapped to EQ-5D-3L index value and visual analogue score (VAS). Multivariable mixed effects linear regression models were adjusted and fit to examine the effect of potentially modifiable factors at baseline on longitudinal EQ-5D-3L index value. Similar models were also fit to assess the effects of change in these factors across follow-up on index value and VAS. Results 2062 participants (68.8%) attended first and 1019 (34.0%) second follow-up. EQ-5D-5L responses worsened over time for index value, VAS and in each dimension. Baseline factors independently associated with worse longitudinal HRQoL were obesity, smoking, sarcopenia, pain, breathlessness, weakness, anxiety, depression and raised parathyroid hormone (PTH), whereas renin-angiotensin-system inhibitor use at baseline was associated with improved HRQoL. The status of factors across follow-up such as persistent obesity, new sarcopenia, increasing phosphate, new and persistent anxiety and depression, and worsening pain were associated with worse HRQoL, whereas improved acidosis, improved pain and weakness were associated with improved HRQoL. Conclusion Several potentially modifiable factors independently associated with HRQoL, and NDD-CKD interventions should consider these as therapeutic targets, as well as part of holistic CKD care.

国家统一肾脏转化研究企业CKD (NURTuRE-CKD)队列中与纵向健康相关生活质量相关的潜在可改变因素
非透析依赖型慢性肾脏疾病(NDD-CKD)患者的健康相关生活质量(HRQoL)比非透析依赖型慢性肾脏疾病患者差。本研究假设可以确定影响NDD-CKD队列纵向HRQoL的潜在可改变因素,以确定改善HRQoL结果的潜在治疗靶点。NURTuRE-CKD队列研究从2017年起从英国肾病中心招募了2996名NDD-CKD患者。在基线和首次随访时收集社会人口学、病史、用药、人体测量、生物标志物和患者报告的结果测量(PROM)数据。第二次随访时测量HRQoL。主要终点为EQ-5D-5L测量HRQoL,并将其映射为EQ-5D-3L指标值和视觉模拟评分(VAS)。对多变量混合效应线性回归模型进行调整和拟合,检验基线潜在可修改因素对纵向EQ-5D-3L指标值的影响。类似的模型也适用于评估这些因素在随访期间的变化对指数值和VAS的影响。结果第一次随访2062例(68.8%),第二次随访1019例(34.0%)。EQ-5D-5L在指标值、VAS和各维度上的反应随着时间的推移而恶化。与较差的纵向HRQoL独立相关的基线因素是肥胖、吸烟、肌肉减少症、疼痛、呼吸困难、虚弱、焦虑、抑郁和甲状旁腺激素(PTH)升高,而基线时使用肾素-血管紧张素系统抑制剂与HRQoL改善相关。持续肥胖、新的肌肉减少症、磷酸盐增加、新的和持续的焦虑和抑郁、疼痛加重等因素的随访状态与HRQoL恶化相关,而酸中毒改善、疼痛和虚弱改善与HRQoL改善相关。结论:与HRQoL和NDD-CKD干预措施独立相关的几个潜在可改变因素应将其视为治疗靶点,以及整体CKD护理的一部分。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
American Journal of Nephrology
American Journal of Nephrology 医学-泌尿学与肾脏学
CiteScore
7.50
自引率
2.40%
发文量
74
审稿时长
4-8 weeks
期刊介绍: The ''American Journal of Nephrology'' is a peer-reviewed journal that focuses on timely topics in both basic science and clinical research. Papers are divided into several sections, including:
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书